Intellectual Property

BrainStorm’s core technologies and methods are subject to the following patent applications:

• The NurOwn TM technology for differentiation of dopamine-producing neuron-like cells is covered by application number PCT/IL03/00972 filed in November 2003.

• The NurOwn TM technology for differentiating astrocyte-like cells is covered by PCT patent application number PCT/IL2006/000699 filed on June 18, 2006.

The patent applications, as well as the relevant know-how and research results, are licensed from Ramot at Tel Aviv University, Ltd, the technology transfer company of Tel Aviv University. BrainStorm and Ramot will work together to protect and enhance its intellectual property rights by filing continuations and new patents to cover any improvements in the NurOwn™ technology and any new discoveries arising in the course of the ongoing R&D program.